Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 35Phase 1 33Phase 1/2 24Phase 2/3 8Phase NA 2Phase 4 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2

Interventions

Standard of Care 70Educational Status 60Interviews as Topic 54Methods 53Practice Guidelines as Topic 52Early Intervention, Educational 49Blood Specimen Collection 48Exercise 47Surveys and Questionnaires 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Radiosurgery 28Palliative Care 22Radiotherapy 20Resistance Training 17Biopsy 17Patient Navigation 16Magnetic Resonance Imaging 15Diet Therapy 13Counseling 13Health Promotion 12Exercise Test 12Therapeutics 10Surgical Procedures, Operative 10Telemedicine 9Restraint, Physical 9Nutrition Assessment 9Genetic Testing 9X-Rays 8Radiation Dose Hypofractionation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × atezolizumab × 90 days × Clear all
NCT07543510 2026-04-22

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

Third Affiliated Hospital, Sun Yat-Sen University

Phase NA Not yet recruiting
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04180072 2026-04-09

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

National Health Research Institutes, Taiwan

Phase NA Active not recruiting
51 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡